Product category:
Laboratory and scientific professional organisations
News Release from: Cancer Research UK
Edited by the Laboratorytalk Editorial
Team on 18 July 2007
Research collaboration in tumour imaging
The three-year research collaboration will be funded by AstraZeneca and focus on the development of cutting-edge real-time fluorescence and confocal imaging techniques
Cancer Research Technology (CRT), the oncology-focused development and commercialisation company and the Beatson Institute for Cancer Research, Glasgow have announced a new research collaboration with AstraZeneca to develop optical imaging techniques for use in cancer research Studies based at the Beatson Institute and led by Cancer Research UK-funded scientists there will develop non-invasive imaging technologies for studying tumour progression, including the investigation of tumour development, invasion and metastasis
This article was originally published on Laboratorytalk on 10 Dec 2003 at 8.00am (UK)
Related stories
New test could prevent more cervical cancer
A new test could be a more effective early warning system for preventing cervical cancer than the traditional smear according to Cancer Research UK scientists
Secrets of rogue cancer molecule revealed
Findings will help accelerate the search for potent and specific drugs that can target the protein and stop the growth and spread of these cancers
The work will form part of a wider initiative by the Beatson Institute to develop imaging as a key technology underpinning its basic cancer research programme.
The collaboration will initially involve the development and validation of fluorescent probes and reporters for deep tissue imaging of specific biological targets.
These will be further developed for the detection of tumour cells, identification of apoptosis or assessment of blood flow.
Ultimately, the studies aim to investigate the mechanism of tumour invasion and assess the effect of therapeutic or molecular intervention.
In addition, methods and software packages for quantifying image data will be explored.
The development of techniques for tumour imaging in real-time is likely to generate important new information relating to the effects of interventions, thereby accelerating drug development.
• Cancer Research UK: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
